Reported about 9 hours ago
Pfizer has initiated a lawsuit to stop Novo Nordisk's unsolicited bid for the drugmaker Metsera, which Novo announced could be valued at up to $9 billion. Pfizer argues that Novo's offer, which competes with Pfizer's own nearly $5 billion bid from September, poses significant regulatory risks and amounts to an illegal attempt to stifle competition. Metsera is currently developing treatments for obesity and diabetes but has no products available on the market.
Source: YAHOO